Understanding RSV Infections in Older Adults
Respiratory syncytial virus (RSV) is a common respiratory virus that usually causes mild, cold-like symptoms. However, RSV can be serious in high-risk individuals like older adults, especially those with underlying heart or lung disease.
RSV infects the lungs and breathing passages leading to complications such as pneumonia, bronchiolitis, and respiratory failure. Over 177,000 older adults are hospitalized with RSV each year in the U.S. with approximately 14,000 deaths.
Thankfully, the first RSV vaccinations specifically approved for adults ages 60 and older are now available, offering vital protection against this respiratory infection.
Who is at Risk from RSV?
RSV can infect people of all ages but tends to cause more severe infection in certain high-risk groups including:
- Older adults, especially over age 65
- People with heart or lung diseases
- Those with a weakened immune system
- Adults living in nursing homes or long-term care facilities
In older populations, underlying conditions like COPD, emphysema, asthma, chronic heart failure or cancer significantly raise risks from an RSV infection leading to acute respiratory illness.
Beyond individual patient risks, RSV outbreaks in senior living communities and extended care facilities result in extremely high rates of hospitalization, complications and death every year due to the close contact.
RSV Signs and Symptoms
In healthy adults, RSV often causes cold-like symptoms similar to the common cold or flu. More specifically, signs of RSV may include:
- Runny nose
- Sore throat
- Cough
- Fever
- Wheezing
- Chest congestion
For older adults, RSV complications can quickly take a dangerous turn involving:
- Difficulty breathing
- Rapid, shallow breathing
- Shortness of breath at rest
- Cyanosis - blue color in lips or nails
- Altered mental status from lack of oxygen
If an older person displays signs of respiratory distress from presumed RSV infection, emergency care is warranted as delay can be life-threatening.
Preventing RSV - Infection Control Basics
RSV prevention strategies focus heavily on infection control as the virus is easy to transmit and spread via airborne droplets or direct contact. Ways older adults can reduce their risk include:
- Frequent hand washing
- Avoiding touching the face
- Coughing into arm or tissue
- Disinfecting shared surfaces
- Avoiding contact with sick individuals
In long term care settings like nursing homes, staff must wear proper PPE during outbreaks to curb facility-wide transmission through strict isolation protocols.
RSV Antiviral Treatments
For high-risk adults hospitalized with severe RSV infection, several antiviral treatments may help shorten the course including:
- Ribavirin - An inhaled antiviral drug given through mechanical ventilation
- Remdesivir - Delivered through IV infusion over 3-5 days
Supportive therapy like oxygen, fluids,and medication to open airways are also key in RSV cases needing ICU treatment to stabilize breathing complications like pneumonia or COPD exacerbation.
RSV Vaccines for Older Adults Over 60
Beyond good hygiene and early drug therapy, RSV vaccines now offer older adults significant protection against developing severe lower respiratory disease requiring hospitalization from this formidable virus.
Newly Approved Senior RSV Vaccines
The FDA approved two first-of-their kind RSV vaccines for adults 60 and over in mid-2022 based on strong late-stage clinical trial data demonstrating high effectiveness at preventing severe illness:
- Nirsevimab - Given as a single shot to prevent RSV lower respiratory disease
- Resvax - Two dose series spaced one year apart for RSV prevention
Both of these newly available immunizations work right away to produce RSV neutralizing antibodies in older adults to fight off infection and thwart progression to dangerous lung involvement.
Who Should Get the New RSV Vaccines?
The CDC currently recommends the new RSV shots specifically for older adults ages 60 and up before peak RSV season begins. Those with the following risk factors should prioritize vaccination:
- Age 65+
- Chronic heart or lung illness
- Weakened immune system
- Living in a long term care facility
Clinical trials showed the most benefit preventing severe infection in these high-risk seniors, supporting universal immunization in this population.
Cost Coverage for Older Adult RSV Vaccination
Most major health insurance plans including Medicare Part B and D are expected to cover the new RSV vaccines as a recommended preventative shot for all enrollees over 60 years old.
Ask your doctor which vaccine is right for you based on your age, medical history, and when peak RSV season hits your local area for proper timing of injection.
Stay in touch with your healthcare team about whether you need a single dose or follow up booster in a year for maintained protection as guidelines evolve.
The Bottom Line on New RSV Vaccines for Seniors
RSV represents a sneaky, often life-threatening respiratory infection disproportionately attacking vulnerable older adults and the chronically ill every year leading to widespread severe illness.
The U.S. approval of breakthrough RSV vaccines specifically tailored to high risk individuals over age 60 promises to dramatically reduce hospitalizations and deaths from this viral threat moving forward.
All older patients are strongly urged to inquire about these paradigm-changing shots from their doctor to finally turn the tables on the long unchecked devastation of annual RSV spread through senior communities and care centers coast to coast.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult with a healthcare professional before starting any new treatment regimen.
Add Comment